134 related articles for article (PubMed ID: 1828092)
1. Efficacy and duration of antistaphylococcal activity comparing three antibiotics bonded to Dacron vascular grafts with a collagen release system.
Chervu A; Moore WS; Chvapil M; Henderson T
J Vasc Surg; 1991 Jun; 13(6):897-901. PubMed ID: 1828092
[TBL] [Abstract][Full Text] [Related]
2. In vitro antistaphylococcal activity of collagen-sealed Dacron vascular prostheses bonded with rifampin, vancomycin, or amikacin.
Magnan PE; Seyral P; Raoult D; Branchereau A
Ann Vasc Surg; 1994 May; 8(3):243-7. PubMed ID: 8043357
[TBL] [Abstract][Full Text] [Related]
3. Antistaphylococcal activity of rifampin-bonded gelatin-impregnated Dacron grafts.
Gahtan V; Esses GE; Bandyk DF; Nelson RT; Dupont E; Mills JL
J Surg Res; 1995 Jan; 58(1):105-10. PubMed ID: 7830398
[TBL] [Abstract][Full Text] [Related]
4. Prevention of graft infection by use of prostheses bonded with a rifampin/collagen release system.
Chervu A; Moore WS; Gelabert HA; Colburn MD; Chvapil M
J Vasc Surg; 1991 Oct; 14(4):521-4; discussion 524-5. PubMed ID: 1833564
[TBL] [Abstract][Full Text] [Related]
5. Limitations in the use of rifampicin-gelatin grafts against virulent organisms.
Koshiko S; Sasajima T; Muraki S; Azuma N; Yamazaki K; Chiba K; Tachibana M; Inaba M
J Vasc Surg; 2002 Apr; 35(4):779-85. PubMed ID: 11932679
[TBL] [Abstract][Full Text] [Related]
6. [Experimental examination concerning the efficacy of silver-coated Dacron prostheses in vascular graft infections following subcutaneous implantation in a standardized infection model].
Hernández-Richter T; Wittmann F; Mayr S; Schmitt-Sody M; Blasenbreu S; Wichmann M; Heiss MM; Schardey HM; Angele MK
Zentralbl Chir; 2003 Mar; 128(3):244-9. PubMed ID: 12739511
[TBL] [Abstract][Full Text] [Related]
7. Prophylaxis against Staphylococcus aureus vascular graft infection with mupirocin-soaked, collagen-sealed dacron.
Ghiselli R; Giacometti A; Goffi L; Cirioni O; Mocchegiani F; Orlando F; Paggi AM; Petrelli E; Scalise G; Saba V
J Surg Res; 2001 Aug; 99(2):316-20. PubMed ID: 11469904
[TBL] [Abstract][Full Text] [Related]
8. Treatment of vascular graft infection by in situ replacement with a rifampin-bonded gelatin-sealed Dacron graft.
Goëau-Brissonnière O; Mercier F; Nicolas MH; Bacourt F; Coggia M; Lebrault C; Pechère JC
J Vasc Surg; 1994 Apr; 19(4):739-41. PubMed ID: 8164289
[TBL] [Abstract][Full Text] [Related]
9. Rifampin protection against experimental graft sepsis.
McDougal EG; Burnham SJ; Johnson G
J Vasc Surg; 1986 Jul; 4(1):5-7. PubMed ID: 2941596
[TBL] [Abstract][Full Text] [Related]
10. Prevention of vascular graft infections with antibiotic graft impregnation prior to implantation: in vitro comparison between daptomycin, rifampin and nebacetin.
Bisdas T; Beckmann E; Marsch G; Burgwitz K; Wilhelmi M; Kuehn C; Haverich A; Teebken OE
Eur J Vasc Endovasc Surg; 2012 Apr; 43(4):448-56. PubMed ID: 22264589
[TBL] [Abstract][Full Text] [Related]
11. Rifampin and Triclosan but not silver is effective in preventing bacterial infection of vascular dacron graft material.
Hernández-Richter T; Schardey HM; Wittmann F; Mayr S; Schmitt-Sody M; Blasenbreu S; Heiss MM; Gabka C; Angele MK
Eur J Vasc Endovasc Surg; 2003 Nov; 26(5):550-7. PubMed ID: 14532885
[TBL] [Abstract][Full Text] [Related]
12. Development of an infection-resistant vascular prosthesis.
Moore WS; Chvapil M; Seiffert G; Keown K
Arch Surg; 1981 Nov; 116(11):1403-7. PubMed ID: 6458258
[TBL] [Abstract][Full Text] [Related]
13. Polycationic peptides as prophylactic agents against methicillin-susceptible or methicillin-resistant Staphylococcus epidermidis vascular graft infection.
Giacometti A; Cirioni O; Ghiselli R; Goffi L; Mocchegiani F; Riva A; Scalise G; Saba V
Antimicrob Agents Chemother; 2000 Dec; 44(12):3306-9. PubMed ID: 11083632
[TBL] [Abstract][Full Text] [Related]
14. Use of an antibiotic-bonded graft for in situ reconstruction after prosthetic graft infections.
Colburn MD; Moore WS; Chvapil M; Gelabert HA; Quiñones-Baldrich WJ
J Vasc Surg; 1992 Oct; 16(4):651-8; discussion 658-60. PubMed ID: 1344030
[TBL] [Abstract][Full Text] [Related]
15. The prophylactic efficacy of rifampicin-soaked graft in combination with systemic vancomycin in the prevention of prosthetic vascular graft infection: an experimental study.
Sacar M; Goksin I; Baltalarli A; Turgut H; Sacar S; Onem G; Ozcan V; Adali F
J Surg Res; 2005 Dec; 129(2):329-34. PubMed ID: 16360378
[TBL] [Abstract][Full Text] [Related]
16. Local application of vancomycin for prophylaxis of graft infection: release of vancomycin from antibiotic-bonded Dacron grafts, toxicity in endothelial cell culture, and efficacy against graft infection in an animal model.
Muhl E; Gatermann S; Iven H; Dendorfer A; Bruch HP
Ann Vasc Surg; 1996 May; 10(3):244-53. PubMed ID: 8792993
[TBL] [Abstract][Full Text] [Related]
17. Prevention of perioperative vascular prosthetic infection with a novel triple antimicrobial-bonded arterial graft.
Aboshady I; Raad I; Vela D; Hassan M; Aboshady Y; Safi HJ; Buja LM; Khalil KG
J Vasc Surg; 2016 Dec; 64(6):1805-1814. PubMed ID: 26626182
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic efficacy against Staphylococcus epidermidis adherent to vascular grafts.
Bergamini TM; McCurry TM; Bernard JD; Hoeg KL; Corpus RA; James BE; Peyton JC; Brittian KR; Cheadle WG
J Surg Res; 1996 Jan; 60(1):3-6. PubMed ID: 8592428
[TBL] [Abstract][Full Text] [Related]
19. A pilot study of a triple antimicrobial-bonded Dacron graft for the prevention of aortic graft infection.
Aboshady I; Raad I; Shah AS; Vela D; Dvorak T; Safi HJ; Buja LM; Khalil KG
J Vasc Surg; 2012 Sep; 56(3):794-801. PubMed ID: 22579134
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial activity, antibiotic retention, and infection resistance of a rifampin-impregnated gelatin-sealed Dacron graft.
Lachapelle K; Graham AM; Symes JF
J Vasc Surg; 1994 Apr; 19(4):675-82. PubMed ID: 8164283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
